Impact of the UK COVID‐19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management
Year: 2021
Type: article
Abstract: Our findings illustrate the widespread collateral impact of implementing measures to mitigate the impact of COVID-19 in people with, or being investigated for diabetes mellitus (DM). Ironically, failure to focus of the wider implications for people with DM and other groups with long-term conditions, may place them at increased risk of poor outcomes from SARS-CoV-2 infection itself, irrespective of the implications for their longer-term health prospects.
DOI: 10.1111/ijcp.13980
Institutions: Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, University of Manchester, Salford Royal Hospital, Mersey and West Lancashire Teaching Hospitals NHS Trust, Whiston Hospital, Royal Oldham Hospital, University Hospitals of North Midlands NHS Trust, Keele University, University of Staffordshire, Royal Stoke University Hospital, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W3116043370